Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.
Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771.
Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
